PhilipRaskinMD

PubMed

• 44 citations
  Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy
  Carlos Arauz-Pacheco, Luis C. Ramirez, Juan M. Rios, Philip Raskin
  The American Journal of Medicine. 1990-12-01
• 717 citations
  Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
  Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause-Steinrauf, Dorothy J. Becker, Stephen E. Gitelman
  The New England Journal of Medicine. 2009-12-10
• 132 citations
  Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
  Mark R. Rigby, Linda A. DiMeglio, Marc Rendell, Eric I. Felner, Jean M. Dostou
  The Lancet. Diabetes & Endocrinology. 2013-12-01

Journal Articles

• Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology Insulin Pump Management Task Force  
  Grunberger G, Abelseth J, Baily TS, Bode BW, Handelsman Y, Hellman R, Jovanovic L, Lane WL, Raskin P, Tamborlane WV, and Rothermel C, Endocrine Practice, 5/5/2014
• Pregabalin in Patients with Inadequately Treated Painful Diabetic Peripheral Neuropathy, A Randomized Withdrawal Trial  
  Raskin P, Huffman C, Toth C, Asmus M J, Messig M, Sanchez, R, and Pauer L, Clin J Pain, 5/1/2014
• Costimulation Modulation with Abatacept in Patients with Recdent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment  
  Orban T, Bundy B, Becker D, DiMeglio L, Gitelman S, Goland R, Gottlieb P, Greenbaum C, Marks J, Monzavi R, Moran A, Peakman M, Raskin P, Russell W, Schatz D, Wherrett ..., Diabetes Care, 4/1/2014
• Intensive Therapy in Newly Diagnosed Type 2 Diabetes: Results of a 6-Year Randomized Trial  
  Harrison L, Adams-Huet B, Li X, Raskin P, and Lingvay I, Journal of Investigative Medicine, 4/1/2014
• Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial  
  Rigby M, DiMeglio L, Rendell M, Feiner E, Dostou J, Gitelman S, Patel C, Griffin K,, Tsalkian E, Gottlieb P, Greenbaum C, Sherry N, Moore W, Monzavi R, Willi S, Raskin..., The Lancet Diabetes and Endocrinology, 12/1/2013
• A novel glucose-insulin infusion maintains perioperative glycaemic control through multiple transitions of care  
  Renthal N, Roe E D, Adams-Huet B, Raskin P, Journal of Perioperative Practice, 10/1/2013
• Iatrogenic hyperinsulinemia in type 1 diabetes: its effect on atherogenic risk markers  
  Wang M-Y, Yu X, Lee Y, McCorkle S K, Clark, G O, Strowig S, Unger R H, and Raskin P, Journal of Diabetes and Its Complications, 1/1/2013
• Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus  
  Raskin P, Diabetes/Metabolism Research and Reviews, 1/1/2013
•  
  Harrison L, Adams-Huet B, Raskin P, Lingvay I, Diabetes Care, 1/1/2012
• Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial  
  Raskin P, Heller S, Honka M, Chang P C, Boss A H, Richardson P C, Amin N, Diabetes, Obesity and Metabolism, 1/1/2012
• Managing inpatient hyperglycemia in a resource-constrained county hospital: the Parkland Memorial Hospital experience  
  Roe ED and Raskin P, Hospital Practice, 1/1/2012
• Doctor, stop needling me: an update on alternative routes of insulin administration  
  Roe E, Woo J, Raskin P, Diabetes Management, 1/1/2012
• In search of improved glucose control: helping the patient decide between insulin injections and infusion pump therapy  
  Roe E, Woo J, Raskin P, Diabetes Management, 1/1/2012
• A comparison of twice-daily biphasic insulin aspart 70/30 and once-daily insulin glargine in persons with type 2 diabetes mellitus inadequately controlled on basal ins...  
  Ligthelm R, Gylvin T, DeLuzio T, and Raskin P, Endocrine Practice, 1/1/2011
• Updated review: improved glycemic control with repaglinide-metformin in fixed combination for patients with type 2 diabetes  
  Richard J, Raskin P, Clinical Medicine Insights: Endocrinology and Diabetes, 1/1/2011
• Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes  
  Pergola P E, Raskin P, Toto R D, Meyer C J, The New England Journal of Medicine, 1/1/2011
• Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial  
  Wherrett D K, Bundy B, Becker D, DiMeglio L A, Gitelman S E, Goland R, Gottlieb P A, Greenbaum C J, Herold K C, Marks J B, Monzavi R, Moran A, Orbon T, Palmer J P, Ras..., The Lancet, 1/1/2011
• Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial  
  Orban T, Bundy B, Becker D, DiMeglio L A, Gitelman S E, Goland R, Gottlieb P A, Greenbaum C J, Marks J B, Monzavi R, Moran A, Raskin P, Rodriguez H. Russell W E, Schat..., The Lancet, 1/1/2011
• A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure  
  Davidson M B, Raskin P, Tannenberg R J, Vlajnic A, Hollander P, Endocrine Practice, 1/1/2011
• The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes  
  Johnson S L, McEwen L N, Newton C A, Martin C L, Raskin P, Halter J B, Herman W H, The Journal of Diabetes and Its Complications, 1/1/2011
• Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes:...  
  Bohannon N, Bergenstal R, Cuddihy R, Kruger D, List S, Massaro E, Molitch M, Raskin P, Remtema H, Strowig S, Whitehouse F, Brunelle RL, Dreon D, Tan M, Diabetes Technology & Theraapeutics, 1/1/2011
• Review of clinical trials: update on oral insulin spray formulation  
  Pozilli P, Raskin P, Parkin CG, Diabetes Obe Metab, 1/1/2010
• Glycaemic control with liraglutide: the phase 3 trial programme  
  Raskin P, Mora P F, Int J Clin Pract., 1/1/2010
• Continuing Glucose Monitoring System: Changing Diabetes Management?  
  Richard J, Raskin P., Infusystems USA, 1/1/2010
• Clinical Dilemmas in Diabetes  
  Richard J, Raskin P, 1/1/2010
• Join now to see all

Books/Book Chapters

• Type 2 Diabetes Milletus, An Evidence-Based Approach to Practical Management 
  Chapter: Type 2 diabetes mellitus: An evidence-based approach to practical management: Noninsulin pharmacological therapies. 
  Page 151 - 167Lingvay I, Rhee C, Raskin PEditors: Feinglos M, Bethel MA.Humana Press, Durham, NC2008
• The Diabetes Mellitus Manual 
  Chapter: Intensive management of type 1 diabetes mellitus. 
  Page 117 - 139Strowig S, Raskin PEditors: Inzucchi A, Porte D, Sherwin RS, Bowen A.McGraw-Hill, New York, NY2004
• International Textbook of Diabetes Mellitus 
  Chapter: Glycemic control and the complication diabetes. 
  Strowig SM, Raskin PEditors: Alberti KGMM, Defronzo RA, Zimmet P.John Wiley & Sons, Ltd., EnglandEdition 2nd,1997
• Ellenberg & Rifkin’s Diabetes Mellitus 
  Chapter: Intensive management of insulin-dependent diabetes mellitus. 
  Page 709 - 734Strowig SM, Raskin PEditors: Porte, Sherwin.Appleton & LangeEdition 5th,1997
• The International Textbook on Diabetes Mellitus 
  Chapter: The genesis of diabetes complications: blood glucose and genetic susceptibility. 
  Rosenstock J, Raskin PEditors: Alberti M, DeFronzo RA, Keen H, Zimmet P.John Wiley & Sons, Chichester, England1992
• Therapy for Diabetes Mellitus and Related Disorders 
  Chapter: Surgery and anesthesia. 
  Arauz-Pacheco C, Raskin PEditors: Lebovitz H, DeFronzo R, Genuth S, Kreisberg R, Pfeifer M, Tamborlane W.American Diabetes Association, Virginia1991
• Textbook of Diabetes 
  Chapter: Pancreatic abnormalities in Type II non-insulin dependent diabetes mellitus. 
  Ramirez L, Raskin PEditors: Pickup J, Williams G.Blackwell Scientific Publications, Oxford1991
• Diabetes and Vascular Disease 
  Chapter: Diabetes and Vascular Disease 
  Page 49 - 86Raskin PEditors: Kerstein MD.J.B. Lippincott Company, Philadelphia, PA1990
• Diabetes Mellitus, Theory and Practice 
  Chapter: Insulin treatment and patient Management. 
  Strowig S, Raskin PEditors: Rifkin H, Porte D.Elsevier Publishing, New York, NY1990
• Current Status of Prevention and Treatment of Diabetic Complications 
  Chapter: Diabetes control and complications: an overview. 
  Page 134 - 141Rosenstock J, Raskin PEditors: Sakamoto N, Alberti KGMM, Hotta N.Excerpta Medica, Amsterdam1990
• The Kidney in Diabetes Mellitus. Contemporary Issues in Nephrology, V20 
  Chapter: Relationship of diabetic nephropathy to glycemic control. 
  Page 1 - 17Rosenstock J, Raskin PEditors: Brenner BM, and Stein JH.Churchill Livingston, New York, NY1989
• Polyol Pathway and Its Role In Diabetic Complications 
  Chapter: The potential effects of the aldose reductase inhibitors on the microvascular complications of diabetes mellitus. 
  Raskin P, Rosenstock JEditors: Sakamoto N, Kinoshita JH, Kador PF, Hotta N.Excerpta Medica, Amsterdam1988
• Recent Trends of Management of Diabetes Mellitus. Proceedings of the Second International Symposium on Treatment of Diabetes Mellitus 
  Chapter: Improved diabetes control reduces skeletal muscle capillary basement membrane width in insulin dependent diabetes mellitus. 
  Page 13 - 15Rosenstock J, Challis P, Strowig S, Raskin PEditors: Sakamoto N, Alberti KGMM, Hotta H.Excerpta Medica, Nagoya, Japan1987
• Diabetes Mellitus: Recent knowledge on aetiology, complications and treatment 
  Chapter: Continuous subcutaneous insulin infusion: current and future developments. 
  Raskin PEditors: Baba S, Gould MK, Zimmet P.Academic Press, Australia, New South Wales1984
• Diabetes Mellitus: Theory and Practice 
  Chapter: Artificial pancreas: open loop systems. 
  Page 941 - 958Raskin PEditors: Ellenberg M, Rifkin H.Medical Examination Publishing Co, New York, NYEdition 3rd,1983
• Diabetes Mellitus and Obesity 
  Chapter: Glucagon. 
  Page 63 - 70Raskin PEditors: Brodoff BN, Bleicher SJ.Williams and Wilkins, Baltimore, MD1982
• The Islets of Langerhans: Biochemistry, Physiology, and Pathology 
  Chapter: Interaction of insulin, glucagon, and somatostatin in diabetes. 
  Raskin PEditors: Cooperstein SJ, Watkins DT.Academic Press1981
• Diabetes Mellitus, V 
  Chapter: Transplants, artificial pancreas and new pharmacological advances. 
  Raskin PEditors: Rifkin H, Raskin P.Robert J. Brady Company, Maryland1981
• Medical Clinics North America 
  Chapter: Glucagon and diabetes. 
  Page 713 - 722Raskin P, Unger RHEditors: Podolsky S.W.B. Saunders Co, Philadelphia, PA1978
• Advances in Polyamine Research Vol. 1 
  Chapter: On the mechanism of activation of hepatic ornithine decarboxylase by cyclic AMP. 
  Page 51 - 58Levine JH, Leaming AB, Raskin PEditors: Campbell RA, Morris DR, Bartos D, Daves GD, Bartos F.Raven Press, New York, NY1978
• Glucagon: Its role in physiology and clinical medicine 
  Chapter: The effects of exogenously induced hyperglucagonemia in insulin treated diabetic. 
  Page 643 - 650Raskin P, Srikant CB, Nakabayashi H, Dobbs RE, Unger RHEditors: Foa PP, Bjaj JS, Foa NL.Springer-Verlag, New York, NY1977
• Recent Progress in Hormone Research 
  Chapter: Glucagon and the A-cells. 
  Page 477 - 517Unger RH, Raskin P, Srikant CB, Orci LEditors: Pincus G.Academic Press, New York, NY1977
• Proceedings of the V International Congress of Endocrinology 
  Chapter: Glucagon, insulin and somatostatin in diabetes. 
  Page 588 - 593Unger RH, Raskin PEditors: James VHT.Excerpta Medica, Hamburg, Amsterdam1976
• Join now to see all